Replies to post #43447 on Biotech Values

[north40000]

Fed. Cir. opinion re Norvasc litigation:

http://www.fedcir.gov/opinions/06-1261.pdf

[palindromy]

This is quite funny, Mylan had lost its case just about a month or so back.
Can anybody educate the board on how Apotex can claim the 6 month exclusivity for being first to file does not hold anymore? Shouldn't this be a victory for Mylan really in the sense that it can launch 6 months earlier than expected.